Acadia Pharmaceuticals (ACAD) Cash from Financing Activities (2010 - 2026)
Acadia Pharmaceuticals' quarterly Cash from Financing Activities came in at $4.2 million in Q1 2026, up 130.2% year-on-year from $1.8 million in Q1 2025, and down 81.33% quarter-over-quarter from $22.7 million in Q4 2025.
Acadia Pharmaceuticals has reported Cash from Financing Activities for 17 years, with the latest figure at $4.2 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 130.2% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $52.3 million (up 584.24% YoY), and the FY2025 full-year result was $49.9 million, up 628.75% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $4.2 million, down from $22.7 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $22.7 million in Q4 2025, with the low at $268000.0 in Q3 2024.
- Average Cash from Financing Activities over 5 years is $5.5 million, with a median of $3.6 million recorded in 2024.
- Year-over-year, Cash from Financing Activities jumped 4342.86% in 2023 and slumped 97.9% in 2024.
- Tracing ACAD's Cash from Financing Activities over 5 years: stood at $1.6 million in 2022, then soared by 236.68% to $5.4 million in 2023, then plunged by 63.77% to $2.0 million in 2024, then jumped by 1051.14% to $22.7 million in 2025, then plunged by 81.33% to $4.2 million in 2026.
- The last three Cash from Financing Activities figures came in at $4.2 million (Q1 2026), $22.7 million (Q4 2025), and $9.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | 4.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.23 Mn |
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 22.67 Mn |
| Dec 31, 2025 | 22.67 Mn |
| Sep 30, 2025 | 9.42 Mn |
| Sep 30, 2025 | 9.42 Mn |
| Jun 30, 2025 | 15.96 Mn |
| Jun 30, 2025 | 15.96 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 268,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 3.57 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 5.43 Mn |
| Dec 31, 2023 | 5.43 Mn |
| Sep 30, 2023 | 12.75 Mn |
| Sep 30, 2023 | 12.75 Mn |
| Jun 30, 2023 | 5.48 Mn |
| Jun 30, 2023 | 5.48 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 287,000.00 |
| Sep 30, 2022 | 287,000.00 |
| Jun 30, 2022 | 3.83 Mn |
| Jun 30, 2022 | 3.83 Mn |
| Mar 31, 2022 | 2.47 Mn |
| Mar 31, 2022 | 2.47 Mn |
| Dec 31, 2021 | 4.37 Mn |
| Dec 31, 2021 | 4.37 Mn |
| Sep 30, 2021 | 1.07 Mn |
| Sep 30, 2021 | 1.07 Mn |
| Jun 30, 2021 | 5.01 Mn |
| Jun 30, 2021 | 5.01 Mn |
| Mar 31, 2021 | 7.73 Mn |
| Mar 31, 2021 | 7.73 Mn |
| Dec 31, 2020 | 18.13 Mn |
| Dec 31, 2020 | 18.13 Mn |
| Sep 30, 2020 | 11.72 Mn |
| Sep 30, 2020 | 11.72 Mn |
| Jun 30, 2020 | 47.40 Mn |
| Jun 30, 2020 | 47.40 Mn |
| Mar 31, 2020 | 3.75 Mn |
| Mar 31, 2020 | 3.75 Mn |
| Dec 31, 2019 | 43.06 Mn |
| Dec 31, 2019 | 43.06 Mn |
| Sep 30, 2019 | 319.97 Mn |
| Sep 30, 2019 | 319.97 Mn |
| Jun 30, 2019 | 4.65 Mn |
| Jun 30, 2019 | 4.65 Mn |
| Mar 31, 2019 | 4.18 Mn |
| Mar 31, 2019 | 4.18 Mn |
| Dec 31, 2018 | 300.60 Mn |
| Dec 31, 2018 | 300.60 Mn |
| Sep 30, 2018 | 211,000.00 |
| Sep 30, 2018 | 211,000.00 |
| Jun 30, 2018 | 2.95 Mn |
| Jun 30, 2018 | 2.95 Mn |
| Mar 31, 2018 | 2.88 Mn |
| Mar 31, 2018 | 2.88 Mn |
| Dec 31, 2017 | 4.79 Mn |
| Dec 31, 2017 | 4.79 Mn |
| Sep 30, 2017 | 7.90 Mn |
| Sep 30, 2017 | 7.90 Mn |
| Jun 30, 2017 | 7.01 Mn |
| Jun 30, 2017 | 7.01 Mn |
| Mar 31, 2017 | 11.49 Mn |
| Mar 31, 2017 | 11.49 Mn |
| Dec 31, 2016 | 3.99 Mn |
| Dec 31, 2016 | 3.99 Mn |
| Sep 30, 2016 | 226.08 Mn |
| Sep 30, 2016 | 226.08 Mn |
| Jun 30, 2016 | 20.76 Mn |
| Jun 30, 2016 | 20.76 Mn |
| Mar 31, 2016 | 282.99 Mn |
| Mar 31, 2016 | 282.99 Mn |
| Dec 31, 2015 | 9.33 Mn |
| Dec 31, 2015 | 9.33 Mn |
| Sep 30, 2015 | 1.13 Mn |
| Sep 30, 2015 | 1.13 Mn |
| Jun 30, 2015 | 2.60 Mn |
| Jun 30, 2015 | 2.60 Mn |
| Mar 31, 2015 | 1.44 Mn |
| Mar 31, 2015 | 1.44 Mn |
| Dec 31, 2014 | 2.81 Mn |
| Dec 31, 2014 | 2.81 Mn |
| Sep 30, 2014 | 1.28 Mn |
| Sep 30, 2014 | 1.28 Mn |
| Jun 30, 2014 | 1.72 Mn |
| Jun 30, 2014 | 1.72 Mn |
| Mar 31, 2014 | 198.04 Mn |
| Mar 31, 2014 | 198.04 Mn |
| Dec 31, 2013 | 629,000.00 |
| Dec 31, 2013 | 629,000.00 |
| Sep 30, 2013 | 974,000.00 |
| Sep 30, 2013 | 974,000.00 |
| Jun 30, 2013 | 109.87 Mn |
| Jun 30, 2013 | 109.87 Mn |
| Mar 31, 2013 | 208,000.00 |
| Mar 31, 2013 | 208,000.00 |
| Dec 31, 2012 | 91.23 Mn |
| Dec 31, 2012 | 91.23 Mn |
| Sep 30, 2012 | 6.86 Mn |
| Sep 30, 2012 | 6.86 Mn |
| Jun 30, 2012 | 57,000.00 |
| Jun 30, 2012 | 57,000.00 |
| Mar 31, 2012 | 22,000.00 |
| Mar 31, 2012 | 22,000.00 |
| Dec 31, 2011 | 97,000.00 |
| Dec 31, 2011 | 97,000.00 |
| Sep 30, 2011 | -10,000.00 |
| Sep 30, 2011 | -10,000.00 |
| Jun 30, 2011 | 47,000.00 |
| Jun 30, 2011 | 47,000.00 |
| Mar 31, 2011 | 13.81 Mn |
| Mar 31, 2011 | 13.81 Mn |
| Dec 31, 2010 | 359,000.00 |
| Dec 31, 2010 | 359,000.00 |
| Sep 30, 2010 | 318,000.00 |
| Sep 30, 2010 | 318,000.00 |